NCI Definition: A benign, borderline, or malignant neoplasm that affects the prostate gland. Representative examples include benign prostate phyllodes tumor, prostatic intraepithelial neoplasia, prostate carcinoma, and prostate sarcoma. [1]

Prostate neoplasms most frequently harbor alterations in TP53, TMPRSS2, ERG, PTEN, and AR [2].

Most Commonly Altered Genes in Prostate Neoplasm

TP53 Mutation, TP53 Missense, TP53 c.217-c.1178 Missense, AR Amplification, and PTEN Loss are the most common alterations in prostate neoplasm [2].

Top Alterations in Prostate Neoplasm

Disease Details

Neoplasm of Prostate, Tumor of Prostate, Neoplasm of the Prostate, Prostate Tumor, Tumor of the Prostate
Male Reproductive System Neoplasm
Benign Prostate Phyllodes Tumor, Prostate Leiomyoma, Malignant Prostate Neoplasm, Prostate Adenoma, and Grade III Prostatic Intraepithelial Neoplasia
OncoTree Name
OncoTree Code


1. National Cancer Institute. NCI Thesaurus Version 18.11d. https://ncit.nci.nih.gov/ncitbrowser/ [2018-08-28]. [2018-09-21].

2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 6. This dataset does not represent the totality of the genetic landscape; see paper for more information.

3. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.